A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
Clinical trial NCT04756323 · UNKNOWN
Trial details
- NCT number
- NCT04756323
- Sponsor
- Beijing Minhai Biotechnology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-06-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.